SU611598A3 - Method of counting leucocytes - Google Patents
Method of counting leucocytesInfo
- Publication number
- SU611598A3 SU611598A3 SU711711809A SU1711809A SU611598A3 SU 611598 A3 SU611598 A3 SU 611598A3 SU 711711809 A SU711711809 A SU 711711809A SU 1711809 A SU1711809 A SU 1711809A SU 611598 A3 SU611598 A3 SU 611598A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- solution
- cells
- staining
- reagent
- hemolysis
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 4
- 239000000243 solution Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 238000010186 staining Methods 0.000 description 11
- 210000000265 leukocyte Anatomy 0.000 description 9
- 206010018910 Haemolysis Diseases 0.000 description 8
- 230000008588 hemolysis Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000093 cytochemical effect Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XIVJNRXPRQKFRZ-UHFFFAOYSA-N naphthalen-1-yl butanoate Chemical compound C1=CC=C2C(OC(=O)CCC)=CC=CC2=C1 XIVJNRXPRQKFRZ-UHFFFAOYSA-N 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-M 1-naphthaleneacetate Chemical compound C1=CC=C2C(CC(=O)[O-])=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-M 0.000 description 2
- DDYBAABYDNWVPI-UHFFFAOYSA-N 4-chloronaphthalene-1-carbaldehyde Chemical compound C1=CC=C2C(Cl)=CC=C(C=O)C2=C1 DDYBAABYDNWVPI-UHFFFAOYSA-N 0.000 description 2
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- JBOPQACSHPPKEP-UHFFFAOYSA-N Indoxyl acetate Chemical compound C1=CC=C2C(OC(=O)C)=CNC2=C1 JBOPQACSHPPKEP-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- PCKPVGOLPKLUHR-UHFFFAOYSA-N indoxyl Chemical group C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 2
- -1 naphthyl chloroacetate Chemical compound 0.000 description 2
- 229960003540 oxyquinoline Drugs 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- DPUSLOQBAPOARC-UHFFFAOYSA-N 1h-indol-3-yl butanoate Chemical compound C1=CC=C2C(OC(=O)CCC)=CNC2=C1 DPUSLOQBAPOARC-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241001352366 Leucoma Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/305—Fixative compositions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/808—Optical sensing apparatus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
- Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
- Y10T436/118339—Automated chemical analysis with a continuously flowing sample or carrier stream with formation of a segmented stream
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Ecology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
1one
Изобретение относитс к области медицины и может быть использовано в диагностической практике дл определени содержани лейкоцитов в крови.The invention relates to the field of medicine and can be used in diagnostic practice for determining the content of leukocytes in the blood.
Известен способ подсчета лейкоцитов путем фиксации, ферментативного окрашивани и гемолиза 1 .There is a method for counting leukocytes by fixation, enzymatic staining and hemolysis 1.
Однако известный способ не обеспечивает дифференциального подсчета лейко1штов от других форменных элементов крови.However, the known method does not provide differential counting of leucomas from other blood corpuscles.
Целью изобретени вл етс дифференциальный подсчет лейкоцитов от других форменных злементов крови, например, с помощью фотометрии .The aim of the invention is the differential count of leukocytes from other blood cells, for example, by means of photometry.
Эта цель достигаетс тем, что фиксацию цельной крови провод т моноальдегидом с последующим гемолизом и окрашиванием цитохимическим субстратом, смешанным с хромогенным сопр гающим реагентом, который не образует внеклеточных макрочастиц, добавлением буферной смеси дл регулировани рН и подогревом полученной смеси от 20 до 55°С в течение 1-10 мин.This goal is achieved by fixing whole blood with monoaldehyde followed by hemolysis and staining with a cytochemical substrate mixed with a chromogenic conjugating reagent that does not form extracellular particulates, adding a buffer mixture to adjust the pH and heating the resulting mixture from 20 to 55 ° C. for 1-10 min.
Кроме того, при окраишвании нейтрофилов и ЭОЗИНОФИ.ИОВ, в качестве цитохимического окрашивающего субстрата используют перекись, а хромогенного сопр гающего реагента - 4-хлор-1-нафтал , а дл окрашивани моноцитов в качестве цитохимического окрашивающего субстрата используют альфа-нафтилбутират, а хромогенного сопр гающего р .агента - гексазоний - парарозанилин.In addition, when staining neutrophils and EOSINOFI.IOV, peroxide is used as a cytochemical staining substrate, 4-chloro-1-naphthal is used as a chromogenic conjugate reagent, and alpha naphthyl butyrate is used as a cytochemical staining substrate, and chromogenic conjugate is used. Hexazonium - pararosaniline.
Способ осуществл ют следующим образом.The method is carried out as follows.
Добавл ют отологический фиксирующий реактив к раствору, содержащему белые кров ные клетки (например, цельную кровь) дл умерщвлени содержащихс там кров ных клеток и иммобилизации содержащихс з клетках каталитических знзимов. Предпочтительными вл ютс пробы жидкости организма, такие, как цельна кровь и спинномозгова жидкость. После добавки фиксирующего реактива раствор обрабатьшают особым цитохимическим веществом, хромогенными осаждающим копулирующим реактивом и буфером.An otologic fixative reagent is added to a solution containing white blood cells (for example, whole blood) to kill the contained blood cells and immobilize the contained catalytic cells. Preferred are body fluid samples, such as whole blood and cerebrospinal fluid. After the addition of fixing reagent, the solution is treated with a special cytochemical substance, chromogenic precipitating copulating reagent and buffer.
Цитологический фиксирующий раствор) представл ет собой преимущественно 0,2-40%-ный водный раствор моноальдегида, такого как формальдегид , бутиральдегид, пропиональдегид и ацетальдегид . Диальдегиды непригодны, так как обуслоливают сетчатую структуру и вызывают внеклеточ ные осаждени .The cytological fixative solution is a predominantly 0.2-40% aqueous solution of monoaldehyde, such as formaldehyde, butyraldehyde, propionaldehyde, and acetaldehyde. Dialdehydes are unsuitable because they cause the mesh structure and cause extracellular precipitation.
Концентраци моноальдегида Должна быть достаточно высока дл умерщвлени клеток, однако , без нарушени активности энзим.The concentration of monoaldehyde should be high enough to kill the cells, however, without disrupting the activity of the enzyme.
Низкие концентрации при 1шзких температурах требуют дополнительного времени. Так, например , при концентрации формальдегида в растворе равной 2%, при 4°С требуетс 12 ч, а при 4%-ной концентрации при 50°С требуетс 2 мин.Low concentrations at low temperatures require additional time. For example, at a concentration of formaldehyde in a solution of 2%, at 4 ° C it takes 12 hours, and at 4% concentration at 50 ° C it takes 2 minutes.
Так как обычно смецювают равные объемы жидкости организма и раствора моноальдегида, крепость альдегадного раствора вл етс двойной по сравнению с концентрацией во врем фиксашш альдегида в растворе.Since equal volumes of body fluid and monoaldehyde solution are usually mixed, the strength of the aldehyde solution is double compared to the concentration during fixation of the aldehyde in solution.
Предпочтительным вл етс 37%-ный раствор формальдегида.A 37% formaldehyde solution is preferred.
Когда жидкость организма, содержаида лейкоциты , представл ет собой цельную кровь, то необходимо осуществить гемолиз лейкоцитов, так как существует опасность, что совпадающее прохождение двух или большего количества красных клеток через фотометрическую счетную стандаю ошибочно может быть прин то как окрашенные лейкоциты или ненормальные клетки. Дл этого осуиюствл ют гемолиз красных кров ных клеток путем добавлени реагента к суспензии клеток, чтобы обусловить разрьш только красных клеток и вьоделение их содержимого (например, гемоглобина ) в .раствор. When the body fluid containing leukocytes is whole blood, hemolysis of leukocytes is necessary, since there is a danger that the coinciding passage of two or more red cells through a photometric counting can be mistakenly taken as painted leukocytes or abnormal cells. For this purpose, hemolysis of red blood cells is carried out by adding the reagent to the cell suspension in order to cause the red cells to be discharged and their contents (for example, hemoglobin) to be discharged into the solution.
Гемолиризующие реагенты не должны сверть1вать взвешенные клетки и не должны мешать протеканию Л1юбых последующих гистохимических реакций путем, например, взаимодействи с какими-либо соединени ми; используемыми дл окрашивани клеток на послещшх этапах.Hemolyzing reagents should not curtail suspended cells and should not interfere with the flow of any subsequent histochemical reactions by, for example, interacting with any compounds; used for staining cells in the post stages.
Гемолиз провод т либо до, либо после окрашивани . Если гемолиз провод т после окрашивани , то это не должно сушественио измен ть окраску или измен ть окрашенные или неокрашенны лейкоциты.Hemolysis is carried out either before or after staining. If hemolysis is carried out after staining, this should not change color or change stained or unstained white blood cells.
Гемолиз провод т введением в раствор, содержащий красные и белые кров ные клетки, водного раствора алифатической кислоты с величиной рН |3,0-5,5. Удовлетворительные результаты дает применение уксусной, пропионовой, масл ной и молочной кислот в концентрации 1-10%.Hemolysis is carried out by introducing into a solution containing red and white blood cells an aqueous solution of aliphatic acid with a pH value of | 3.0-5.5. Satisfactory results are obtained by using acetic, propionic, butyric, and lactic acids in a concentration of 1–10%.
Предпочтительным вл етс раствор уксусной кислоты концентрации около 7%. Раствор может быть нагрет до температур, начина от 40 (в течение 8 мин) до 55°С (в течение 1 мин), чем достигаетс инактиваци энзима катализы, снижение псевдопероксидазной активности гемоглобина и ускорение гемолиза. При более низких температурах дл реак1ии требуетс больше времени. Использование еще более высоких температур инактивирует энзимы пероксидазы и ускор ет свертывание после введени гемолизирующего реагента.Acetic acid solution of about 7% is preferred. The solution can be heated to temperatures ranging from 40 (within 8 minutes) to 55 ° C (within 1 minute), which results in inactivation of the catalysis enzyme, reduction of the hemoglobin pseudoperoxidase activity and acceleration of hemolysis. At lower temperatures, reaction takes longer. The use of even higher temperatures inactivates peroxidase enzymes and accelerates clotting after the introduction of the hemolyzing agent.
Окрашивание клеток требует тщательного выбора реактивов. Используют большое ко;шчествоCell staining requires careful selection of reagents. They use a lot of quality
известных цитохимических субстратов. Так дл окрашивани клеток, содержащих пероксидазу, таких как эозинофилы или нейтрофилы, примен ют смес§ неорганической или органической перекиси и 4-хпоро-1-нафтала . Перекись и 4-хлоро.1-нафтал служат в качестве энзимных субстратов, а 4-хлоро-1нафтал служит также в качестве копулирующего реагента. 4-Хлрро-1-нафтал производит темно-синее окрашивание внутри содержащей пероксидазу клетки без введени отдельного хромогенного осаждающего копулирующего реактива. Можно также использовать смесь (7-толидина и 4-хлоро-Ьнафтала дл получени пурпурно-красного красител , если используемый на ступени фиксировани формальресид инактивирован.known cytochemical substrates. Thus, a mixture of inorganic or organic peroxide and 4-hporo-1-naphthal is used to stain cells containing peroxidase, such as eosinophils or neutrophils. Peroxide and 4-chloro.1-naphthal serve as enzyme substrates, and 4-chloro-1 naphthal also serves as a copulating reagent. 4-Chlrro-1-naphthal produces a dark blue stain inside the peroxidase-containing cell without the introduction of a separate chromogenic precipitating copulating reagent. It is also possible to use a mixture of (7-tolidine and 4-chloro-baphthal to produce a purple-red dye if the formalreside used in the fixation step is inactivated.
Дл избирательного окрашивани контролируют рН раствора. Если рН раствора ниже 3,0, то т желые осадки красител образуютс только в зозинофилах. Если рН раствора находитс в пределах 3,0-5,0, то т желые осадки красител образуютс только в нейтрофилах. Если рН находитс в пределах 5,0-7,0, то т желые осадки красител образуютс только в эозинофилах и нейтрофилах.The pH of the solution is monitored for selective staining. If the pH of the solution is below 3.0, then heavy precipitates of the dye are formed only in the rosinophils. If the pH of the solution is in the range of 3.0-5.0, then heavy precipitates of the dye are formed only in neutrophils. If the pH is in the range of 5.0-7.0, then heavy precipitates of the dye are formed only in eosinophils and neutrophils.
ЕСЛИ окрашивают липазосодержащие клетки,IF stained with lipase-containing cells,
т.е. моноциты, то используют комбинации сложного эфира, нафтола, такого как 1-нафтилацетата или 1-нафтилбутирата и диамониевой соли, например , гексазоний - парарозанилии, который вл етс хромогенным осаждающим копулирующим реагентом; рН дл этой реакции окрашивани 5,56 ,5, предпочтительно около 6,0, при такой рН т желые осадки красителей образуютс только в моноцитах .those. monocytes, then combinations of an ester, naphthol, such as 1-naphthylacetate or 1-naphthylbutyrate and a diamonium salt, such as hexazonium — pararosanilium, which is a chromogenic precipitating copulating reagent; The pH for this dyeing reaction is 5.56, 5, preferably about 6.0, at this pH, heavy precipitates of dyes are formed only in monocytes.
С целью адекватного цветного окрацшвани For the purpose of adequate color painting
в моноцитах за короткий отрезок времени, например за 5 мин концентраци субстрата должна превышать примерно 0,5 мг/мл в окончательном инкуба1шонном растворе. Сложные зфиры нафтал-AS и их производные и 1-нафтилбутират менее растворимы, чем 0,5 мг/мл, поэтому в них ввод т 2,2-оксидиэтанол (диэтиленгликоль) или другие водные спирты или эфиры, например этиленгликоль, пропиленгликоль, диметиловый эфир этиленгликол in monocytes in a short period of time, for example, in 5 minutes, the concentration of the substrate should exceed about 0.5 mg / ml in the final incubation solution. Naphthal-AS esters and their derivatives and 1-naphthylbutyrate are less soluble than 0.5 mg / ml, therefore 2,2-oxydiethanol (diethylene glycol) or other aqueous alcohols or ethers, for example ethylene glycol, propylene glycol, dimethyl ether, are introduced into them. ethylene glycol
к диэтилкарбитол .to diethylcarbitol.
После этого 1-нафтилбутират и 1-нафтилацетат могут быть растворены в концентраци х до 1 мг/мл. Могут быть растворены также и другиеThereafter, 1-naphthylbutyrate and 1-naphthyl acetate can be dissolved at concentrations up to 1 mg / ml. Others may also be dissolved.
субстраты, такие как нафтилхлорацетат, сложные индоксильные эфиры, такие как сложные эфиры индоксилацетата, индоксилпропионата и индоксилбутирата , сложные эфиры 8-оксихино;тина, такие как 8-оксихинолинацетат, 7-оксихииолиниропиоиатsubstrates, such as naphthyl chloroacetate, indoxyl esters, such as esters of indoxyl acetate, indoxyl propionate and indoxyl butyrate, esters of 8-hydroxychino; tina, such as 8-hydroxyquinoline, 7-hydroxyiiioliniropioate
и 8-оксихинолинбутарат. При тех же услови х будет растворено только около 0,1 мг/мл нафтал-AS-ацетата , что приводит к значительно более слабому вы влению цветного окрашива1ш . Другие сложные зфиры производных иафтал-AS раствор ютс даже в меньшей степени.and 8-hydroxyquinoline butarate. Under the same conditions, only about 0.1 mg / ml of naphthal-AS-acetate will be dissolved, which leads to a significantly weaker color staining. Other ester derivatives of the afatal-AS are even less soluble.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8533370A | 1970-10-30 | 1970-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
SU611598A3 true SU611598A3 (en) | 1978-06-15 |
Family
ID=22190904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU711711809A SU611598A3 (en) | 1970-10-30 | 1971-10-29 | Method of counting leucocytes |
Country Status (12)
Country | Link |
---|---|
US (1) | US3741875A (en) |
JP (2) | JPS576932B1 (en) |
AU (1) | AU460469B2 (en) |
BE (1) | BE774311A (en) |
CA (1) | CA960947A (en) |
DE (1) | DE2153479B2 (en) |
FR (1) | FR2113336A5 (en) |
GB (1) | GB1331568A (en) |
IT (1) | IT961518B (en) |
NL (1) | NL172463C (en) |
SE (1) | SE372417B (en) |
SU (1) | SU611598A3 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2125699B2 (en) * | 1971-05-25 | 1973-05-17 | Phywe AG, 3400 Gottingen | PREPARATION OF CELLS FOR THE MEASUREMENT OF DNA |
US4049381A (en) * | 1976-03-23 | 1977-09-20 | Technicon Instruments Corporation | Apparatus and method of fluid sample analysis |
US4099917A (en) * | 1977-07-21 | 1978-07-11 | Technicon Instruments Corporation | Process for preparing a cell suspension from blood for discrimination of white blood cells and platelets from other blood particles |
DE2826965A1 (en) * | 1978-06-20 | 1980-01-17 | Boehringer Mannheim Gmbh | DIAGNOSTIC AGENT FOR DETECTING LEUCOCYTES IN BODY LIQUIDS AND CHROMOGENES SUITABLE FOR THIS |
US4581223A (en) * | 1980-03-12 | 1986-04-08 | Lawrence Kass | Individual leukocyte determination by means of differential metachromatic dye sorption |
US4492752A (en) * | 1982-09-03 | 1985-01-08 | Ortho Diagnostics Systems Inc. | Method for discriminating between unstained and absorbing dye stained cells |
CA1254134A (en) * | 1984-03-28 | 1989-05-16 | Mount Sinai School Of Medicine Of The City University Of New York | Specific binding flow cytometry method |
US4654312A (en) * | 1984-05-14 | 1987-03-31 | Becton, Dickinson And Company | Lysing agent for analysis of peripheral blood cells |
US4751179A (en) * | 1984-05-31 | 1988-06-14 | Coulter Electronics, Inc. | Method and reagents for differential determination of four populations of leukocytes in blood |
US4801549A (en) * | 1985-09-06 | 1989-01-31 | Technicon Instruments Corporation | Method for the determination of a differential white blood cell count |
US4978624A (en) * | 1985-09-06 | 1990-12-18 | Technicon Instruments Corporation | Reagent for the determination of a differential white blood cell count |
AU602129B2 (en) * | 1985-09-06 | 1990-10-04 | Technicon Instruments Corportion | Method for the determination of a differential white blood cell count |
US5389549A (en) * | 1987-05-29 | 1995-02-14 | Toa Medical Electronics Co., Ltd. | Method for classifying leukocytes and a reagent used therefor |
AU3182289A (en) * | 1988-02-10 | 1989-09-22 | Nygene Corporation | Process for producing biochemicals |
US5316725A (en) * | 1991-06-07 | 1994-05-31 | Edward Lawrence Carver, Jr. | Reagent system for the improved determination of white blood cell subpopulations |
US5262329A (en) * | 1991-06-13 | 1993-11-16 | Carver Jr Edward L | Method for improved multiple species blood analysis |
US6046019A (en) * | 1991-07-09 | 2000-04-04 | Goumeniouk; Alexander P. | Diagnostic kits and methods for making granulocyte cell counts |
US6509192B1 (en) * | 1992-02-24 | 2003-01-21 | Coulter International Corp. | Quality control method |
US6362003B1 (en) | 1992-02-24 | 2002-03-26 | Coulter Corporation | Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof |
ATE193603T1 (en) * | 1992-02-24 | 2000-06-15 | Coulter Corp | SUSPENSION MEDIA FOR HEMATOLIGIC COMPOSITIONS AND METHOD FOR THEIR USE |
AU665413B2 (en) * | 1992-02-24 | 1996-01-04 | Coulter International Corporation | Hematology control composition for leukocyte analogs; and methods for their preparation and use |
US6812032B1 (en) * | 1993-01-21 | 2004-11-02 | Cdc Technologies, Inc. | Apparatus and method for making a plurality of reagent mixtures and analyzing particle distributions of the reagent mixtures |
US5599501A (en) * | 1994-11-10 | 1997-02-04 | Ciba Corning Diagnostics Corp. | Incubation chamber |
WO1996034283A1 (en) * | 1995-04-27 | 1996-10-31 | Hematronix, Inc. | Lytic system utilizing propionic acid for leukocytes differentiation |
US5639630A (en) * | 1995-05-16 | 1997-06-17 | Bayer Corporation | Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes |
US5686308A (en) * | 1995-06-08 | 1997-11-11 | Coulter Corporation | Reagent and method for differential determination of leukocytes in blood |
US5843608A (en) * | 1995-06-08 | 1998-12-01 | Coulter International Corp. | Reagent and method for differential determination of leukocytes in blood |
US6146901A (en) * | 1997-06-16 | 2000-11-14 | Hematronix, Inc. | Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition |
US6759246B1 (en) | 2001-11-30 | 2004-07-06 | Research & Diagnostic Systems, Inc. | Hematology control composition including lymphocyte analogs and method for preparation and use |
CA2428740A1 (en) | 2002-05-20 | 2003-11-20 | Bayer Corporation | Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid (csf) |
EP2525222A1 (en) | 2011-05-17 | 2012-11-21 | Markus M. Heiss | Initial relative lymphocyte count as predictive biomarker |
US11072843B2 (en) | 2016-09-27 | 2021-07-27 | Novelis Inc. | Systems and methods for non-contact tensioning of a metal strip |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2807416A (en) * | 1953-07-13 | 1957-09-24 | Ohio Commw Eng Co | Device for automatically counting blood cells |
DE1200577B (en) * | 1962-05-29 | 1965-09-09 | Habil Hans Meyer Doering Dr Me | Arrangement for counting the particles carried in a flow-capable and translucent medium that influence the brightness of a light beam directed at them |
US3413464A (en) * | 1965-04-29 | 1968-11-26 | Ibm | Method for measuring the nucleic acid in biological cells after enhancement in an acidic solution |
US3523733A (en) * | 1966-01-05 | 1970-08-11 | Technicon Corp | Method and apparatus for particle counting |
US3427135A (en) * | 1966-07-11 | 1969-02-11 | Technicon Instr | Hematology apparatus |
-
1970
- 1970-10-30 US US00085333A patent/US3741875A/en not_active Expired - Lifetime
-
1971
- 1971-10-21 AU AU34847/71A patent/AU460469B2/en not_active Expired
- 1971-10-21 CA CA125,753A patent/CA960947A/en not_active Expired
- 1971-10-22 BE BE774311A patent/BE774311A/en not_active IP Right Cessation
- 1971-10-26 GB GB4971771A patent/GB1331568A/en not_active Expired
- 1971-10-27 DE DE2153479A patent/DE2153479B2/en active Granted
- 1971-10-27 SE SE7113658A patent/SE372417B/xx unknown
- 1971-10-28 IT IT30496/71A patent/IT961518B/en active
- 1971-10-28 FR FR7138709A patent/FR2113336A5/fr not_active Expired
- 1971-10-29 SU SU711711809A patent/SU611598A3/en active
- 1971-10-29 JP JP8567171A patent/JPS576932B1/ja active Pending
- 1971-11-01 NL NLAANVRAGE7114995,A patent/NL172463C/en not_active IP Right Cessation
-
1980
- 1980-07-03 JP JP9002780A patent/JPS56163455A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB1331568A (en) | 1973-09-26 |
AU3484771A (en) | 1973-05-03 |
BE774311A (en) | 1972-04-24 |
FR2113336A5 (en) | 1972-06-23 |
US3741875A (en) | 1973-06-26 |
DE2153479B2 (en) | 1975-06-05 |
SE372417B (en) | 1974-12-23 |
DE2153479A1 (en) | 1972-05-04 |
CA960947A (en) | 1975-01-14 |
JPS56163455A (en) | 1981-12-16 |
NL172463C (en) | 1983-09-01 |
AU460469B2 (en) | 1975-04-24 |
NL7114995A (en) | 1972-05-03 |
JPS576932B1 (en) | 1982-02-08 |
IT961518B (en) | 1973-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU611598A3 (en) | Method of counting leucocytes | |
DE2153479C3 (en) | ||
Vermylen et al. | A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test) | |
Tracey | Chitinase in some Basidiomycetes | |
ES2367979T3 (en) | PROCEDURE FOR DETECTING AND LISTING MICROORGANISMS QUICKLY IN PREPARATIONS OF CELLS OF MAMMALS USING THE BIOLUMINISCENCE OF ATP. | |
US3630847A (en) | Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances | |
Oliver et al. | [33] Use of horseradish peroxidase and fluorescent dextrans to study fluid pinocytosis in leukocytes | |
Gallyas et al. | Copper-H2O2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction. | |
JPS60259185A (en) | Method for obtaining glycerine oxidase | |
US4493892A (en) | Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations | |
Blum et al. | Oxidation of serotonin and 5-hydroxyindoles during the denaturation of oxyhaemoglobin | |
Edson | The oxidation of lactic acid by Mycobacterium phlei | |
Schothorst et al. | Metabolic aspects of the photodynamic effect of protoporphyrin in protoporphyria and in normal red blood cells | |
Goff | A light and electron microscopic study of peroxidase localization in the onion root tip | |
Van Noorden et al. | A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes: I. Optimalization of the staining procedure | |
O'brien | Identification of haemoglobin by its catalase reaction with peroxide and o-dianisidine | |
Gordon et al. | Estimation of lactic acid in biological material by oxidation with ceric sulphate | |
Jung et al. | An improved reagent system for the measurement of serum uric acid | |
US2990338A (en) | Composition for determination of glucose in body fluids | |
US3616259A (en) | Screening procedure for enzyme deficiencies | |
Gowenlock | The estimation of tryptic activity in duodenal contents | |
US3362886A (en) | Composition and method for the detection of galactose | |
US4030885A (en) | Bilirubin determination | |
Ribarov et al. | A chemiluminescent method for measurement of activated oxygen forms in biological fluids and homogenates | |
Begemann et al. | Staining methods |